Analysis of individuals with the APOE ε33 genotype included 52,219 individuals for Alzheimer’s disease, all dementia, and vascular dementia, 50,583 for ischemic cerebrovascular disease, and 48,095 for ischemic heart disease (right panel). Here, APOE is linked to coronary artery disorder.